维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="Wagner SL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Inhibitors of Urokinase and thrombin in culture neurol cell显示文摘	Wagner SL Lau AL Nguyen A	1991	J Neurochem1991，56，：	1
2	Clearance of Alzheimer' s Abeta peptide: the many roads to perdition 显示文摘	TANZI RE MOIR RD WAGNER SL	2004	Neuron2004，43，5：	1
3	Clearance of Alzheimer' s Abeta peptide : the many roads to perdition 显示文摘	Tanzi RE Moir RD Wagner SL	2004	Neuron2004，43，5：	1
4	Current clinical and preclinical photosensitizers for use in photodynamic therapy显示文摘	Detty MR Gibson SL Wagner SJ	2004	J Med Chem2004，47，16：	1
5	Clearance of Alzheimer' s Abeta peptide:the many roads to perdition显示文摘	Tanzi RE Moir RD Wagner SL		0，，05：	1
6	Effect of graft-versus-host diseaseprophylaxis on 3-year diseasefree survival in recipients of unrelated donor bone marrow(T-cell Depletion Trial):a multi-centre,randomised PhaseⅡ-Ⅲtrial显示文摘	Wagner JE Thompson JS Carter SL	2005	Lancet2005，366，9487：	1
7	Reactive oxygen species-activated Ca2 +/calmodulin kinase Ⅱ δ is required for late Ⅰ(Na) augmentation leading to cellular Na and Ca overload显示文摘	Wagner S Ruff HM Weber SL		0，，：	1
8	Motor impairments after meth- amphetamine-induced neurotoxicity in the rat 显示文摘	Walsh SL Wagner GC	1992	J Pharmacol Exp Ther1992，263，2：	1
9	Clearance of Alzheimer's Abeta peptide:the many roads to perdition显示文摘	Tanzi RE Moir RD Wagner SL		0，，05：	1
10	Effect of graft-versus-host disease prophylaxis on 3-year disease free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi -centre, randomised phase II - III trial 显示文摘	WAGNER JE THOMPSON JS CARTER SL	2005	Lancet2005，366，9487：	1
11	γ-Secretase modulators re- duce endogenous amyloid 1342 levels in human neural progenitor cells without altering neuronal differentiation 显示文摘	D'Avanzo C Sliwinski C Wagner SL Tanzi RE Kim DY Kovacs DM	2015	FASEB J2015，29，8：	1
12	Clearance of Alzheimer's Abeta peptide:the many roads to perdition显示文摘	Tanzi RE Moir RD Wagner SL		Neuron0，，：	1
13	Current clinical and preclinical photosensitizers for use in photodynamic therapy显示文摘	Gibson SL Wagner SJ	2004	J Med Chem2004，47，：	1
14	Clearance of Alzheimer' s A~ Peptide: the many roads to perdition显示文摘	Tanzi RE Moir RD Wagner SL	2004	Neuron2004，43，：	1
15	ROS-activated Ca/calmodulin kinase Ⅱd is required for late INa augmentation leading to cellular Na and Ca overload显示文摘	Wagner S Ruff HM Weber SL	2011	Circ Res2011，108，：	1
16	Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study显示文摘	Wagner LM Perentesis JP Reid JM Ames MM Safgren SL Nelson MD Jr	2010	Pediatr Blood Cancer2010，54，4：	1
17	Clearance of Alzheimer' s Abeta peptide :the many roads to perdition 显示文摘	Tanzi RE Moir RD Wagner SL	2004	Neuron2004，43，5：	1
18	Clearance of Alzheimer's Abeta peptide; the many roads to perdition 显示文摘	Tanzi RE Moir RD Wagner SL	2004	Neuron2004，43，5：	1
19	Mathematical aspects of divergent beam radiography显示文摘	Smith KT Solmon DC Wagner SL		0，，：	1
20	Clearance of Alzheimer' s Aβ peptide: the many roads to perdition显示文摘	Tanzi RE Moir RD Wagner SL	2004	Neuron2004，43，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示